Malaria can be a lifethreatening condition, especially if youre infected with the parasite p. These guidelines consist of recommendations on the diagnosis and treatment of uncomplicated and severe malaria, including among atrisk populations young children, pregnant women, tuberculosis or hivaids patients, nonimmune travellers, in epidemic situations and in humanitarian emergencies. Studies of the association between malaria in pregnancy mip and malaria during infancy have provided mixed results. In line with who guidelines, pmi supports a threepronged approach to reducing malaria in pregnancy. Can be used in second and third trimesters of pregnancy. The seaquamat trial showed it to be superior to parenteral quinine in asian adults 32. Improving malaria treatment during pregnancy medicines. The objectives of treatment for severe malaria are to prevent death, neurological deficit and. Published data on use of this drug during pregnancy include randomized controlled trials, intervention trials, prospective and retrospective cohort. This guideline provides clinicians with evidencebased information on the diagnosis and treatment of malaria in pregnancy in situations likely to be encountered in uk medical practice. Intravenous quinine has traditionally been the treatment drug of choice for severe malaria in pregnancy. The recommended treatment for severe malaria at any time in pregnancy is with parenteral artesunate 31. Treatment of vivax malaria diagnosis of vivax malaria may be made by the use of rdt bivalent or microscopic examination of the blood smear. Use of antimalarials to treat malaria is considered acceptable.
Most experience on its use in treatment of malaria in pregnancy comes from southeast asia where mq was administered primarily in combination with artesunate as and where increasing resistance to mq has been reported 38, 39. Effective interventions have been put in place to protect this highly vulnerable population over the past few years. Malaria infection during pregnancy can lead to miscarriage, premature delivery, low birth weight, congenital infection, andor perinatal death. Impact of plasmodium falciparum malaria and intermittent. In africa, a metaanalysis showed threecourse or monthly iptp with sulfadoxinepyrimethamine to be. Malaria remains one of the most preventable causes of adverse birth outcomes. Who recommends a specific package of interventions for the prevention and treatment of malaria during pregnancy. With 125 million women at risk of malaria in pregnancy every year, better diagnostic tools are needed for timely identification and treatment of malaria infection. Uk malaria treatment guidelines 2016 sciencedirect. After hours or on weekends and holidays, clinicians requiring assistance should call the cdc emergency operations center at 7704887100 and ask the operator. Malaria continues to take a great toll on our pregnant women and their babies. When a pregnant woman presents with severe malaria, the priority is to save her life.
Malaria during pregnancy is a major public health concern and an important contributor to maternal and infant morbidity and mortality in malariaendemic countries. Malaria infection during pregnancy is a significant public health problem with substantial risks for the woman, her fetus and the newborn child. During pregnancy, a woman faces a much higher risk of contracting. In 2006, the who recommended a combination of quinine and clindamycin for treatment of uncomplicated malaria in pregnancy. Malaria chapter 4 2020 yellow book travelers health. Can be used in first trimester of pregnancy if no other drug options are available. Quinine may be used in the first trimester if there is concern about resistant vivax. In africa, malaria infection in pregnancy is a major threat to the lives of mothers, fetuses, and infants. Severe malaria in pregnancy is a large contributor to maternal morbidity and mortality. Malaria infection in pregnancy is a major cause of maternal death, maternal anemia, and adverse pregnancy outcome spontaneous abortion, preterm delivery, growth restrictionlow birth weight, stillbirth, congenital infection, neonatal mortality in geographic areas where malaria infection occurs commonly in pregnant women. Prevention of malaria in pregnancy the lancet infectious. Effectiveness of intermittent screening and treatment for.
Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy. During the first trimester of pregnancy, quinine in combination with clindamycin remains the recommended drug, 1 due to a historic lack of safety evidence regarding the use of act in this delicate period of foetal development. This study aimed to estimate the proportion of and identify factors associated with the uptake of at least three doses of iptp with sp among pregnant women in malawi after the adoption and. Both direct and indirect costs associated with a malaria episode represent a substantial burden on the poorer households. Treatment for the disease is typically provided in a hospital. Malaria infections are generally asymptomatic, and the current control strategy is based on the prevention of infections 6. Read more about standby emergency treatment for malaria.
On confirmation following treatment is to be given. Clinicians who require assistance with the diagnosis or treatment of malaria should call the cdc malaria hotline 7704887788 or tollfree at 85585647 from 9 am to 5 pm eastern time. Malaria during pregnancy is a major cause of anemia and maternal death and one of the main causes of low birthweight 1,2. Treatment of uncomplicated malaria in pregnancy is a balance between potential fetal adverse effects from drug toxicity and improved clinical status with clearance of the parasite. Malaria in pregnancy is an obstetric, social and medical problem requiring multidisciplinary and multidimensional solution. The safety of mefloquine when used for the treatment of malaria in pregnancy. If youre pregnant, its advisable to avoid travelling to areas where theres a risk of malaria. Knowledge, attitude and practice on malaria prevention and. Malawi adopted the 2012 updated word health organization who intermittent preventive treatment of malaria during pregnancy with sulphadoxinepyrimethamine iptpsp policy in 20. Please note that if the patient has signs and symptoms of severe malaria, presumptive treatment should.
Recommended interventions for malaria prevention and control during pregnancy policies for malaria prevention and control during pregnancy in areas of stable transmission should emphasize a package of intermittent preventive treatment and use of insecticidetreated nets and ensure effective case management of. Data from published studies in pregnant women have shown no increase in the risk of teratogenic effects or adverse pregnancy outcomes after treatment or prophylaxis with this drug during pregnancy. Pdf intermittent treatment for the prevention of malaria. Intermittent treatment for the prevention of malaria during pregnancy in benin. However, recent randomized clinical trials rcts indicate that intravenous artesunate is more efficacious for treating severe malaria, resulting in changes to the world health organization who. Chloroquine is a safe option for treatment of nonfalciparum malaria throughout pregnancy.
Intermittent preventive treatment of malaria for pregnant women iptp is a very important strategy for the control of malaria in pregnancy in malariaendemic tropical countries, where mosquito. Malaria in pregnancy mip is a major public health problem, contributing substantially to morbidity and mortality among pregnant women, developing fetuses and newborn babies in endemic areas. Malaria in pregnancy, diagnosis and treatment greentop. Malaria in pregnancy national malaria control programme. Intermittent preventive treatment in pregnancy iptp with sulfadoxinepyrimethamine is used to prevent malaria, but resistance to this drug combination has decreased its efficacy and new alternatives are needed. Who recommends a package of interventions for preventing and controlling malaria during pregnancy, which includes promotion and use of insecticidetreated nets, appropriate case management with prompt, effective treatment, and, in areas with moderate to high transmission of plasmodium falciparum, administration of iptpsp 1. Plasmodium infections are notable causes of adverse birth outcomes, including fetal loss, intrauterine growth retardation, and preterm delivery. Pregnant women constitute the main adult risk group for malaria and 80% of deaths due to malaria in africa occur in pregnant women and children below 5 years.
For pregnant women diagnosed with uncomplicated malaria caused by p. Pregnant women have an increased risk of developing severe malaria, and both. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisininpiperaquine versus intermittent preventive treatment with sulfadoxinepyrimethamine for the control of malaria during pregnancy in western kenya. The advisory committee on malaria prevention have agreed to take over and update this guideline. Uptake of intermittent preventive treatment for malaria. Guidelines for treatment of malaria in the united states. Who recommendation on intermittent preventive treatment of. This drug should not be used during pregnancy unless the benefit outweighs the risk to the fetus. This is the second in a series of three papers about malaria in pregnancy. This involves the administration of intermittent preventive treatment ipt of malaria in pregnancy using sulfadoxine pyrimethamine iptpsp during preg.
The objectives of treatment for uncomplicated malaria are to cure radical the infection rapidly, prevent progression to severe disease, reduce transmission of the infection to others and prevent the emergence of antimalarial drug resistance. It is hyper endemic in ghana and among pregnant women, it accounts for17. Consequently, the world health organization who recommends protection for women during pregnancy. Pregnancyassociated malaria pam or placental malaria is a presentation of the common illness that is particularly lifethreatening to both mother and developing fetus. The first reports on the use of mq in pregnant women are from the late 1980s 36, 37. Acts can be used in the second and third trimesters. Pam is caused primarily by infection with plasmodium falciparum, the most dangerous of the four species of malariacausing parasites that infect humans.
1475 771 221 951 915 617 1299 1237 410 1268 930 669 1214 191 1005 95 1124 941 1386 370 657 119 193 1328 1345 316 218 971 165 246 1207